Drug intelligence / Profile preview

weiyan no. 2

Development stage: Unknown
Lead developer: Zhejiang Chinese Medical University
Modality: Small Molecules
Administration: Oral

Overview

Weiyan No. 2 (胃炎2号颗粒剂) is a traditional Chinese medicine (TCM) formulation in granule form, used primarily for the treatment of chronic erosive gastritis and precancerous gastric lesions. The formula is based on classical TCM principles and typically contains a combination of herbal ingredients designed to regulate qi, harmonize the stomach, reduce inflammation, promote mucosal healing, and relieve pain associated with chronic gastritis. Clinical studies have shown its use in improving symptoms such as epigastric pain and discomfort in patients with chronic erosive gastritis combined with precancerous changes[2]. The product is administered orally as granules dissolved in warm water after meals.

Brand names: 胃炎2号颗粒剂
Other names: Weiyan No. 2胃炎二号颗粒剂安胃二号方免煎颗粒

Beyond the preview

Go deeper on weiyan no. 2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on weiyan no. 2.

Explore the full profile